EP4249512
STÖÐUG MÓTEFNASAMSETNING
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.3.2018EP published:
23.7.2025EP application number:
23177973.7
EP translation filed:
7.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
22.3.2038Expiry date:
22.3.2027Next due date:
31.3.2027
Title in English:
STABLE ANTIBODY FORMULATIONLanguage of the patent:
English
Timeline
Today
23.3.2018EP application
23.7.2025EP Publication
7.8.2025Translation submitted
15.9.2025Registration published
22.3.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
HU, QingyanAddress:
Tarrytown, 10591, US
Name:
LIU, DingjiangAddress:
Tarrytown, 10591, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201762482270 PDate:
6.4.2017Country:
US
Classification
Categories:
A61K 9/00, A61K 39/00, A61K 47/18, A61K 47/26, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 20.3.2026
Expires: 22.3.2027
Payer: Árnason Faktor ehf.